Since Trump’s inauguration, the federalist struggle has intensified between red and blue states, clashing over issues such as abortion, redistricting, voting rights, vaccines, and immigration. The autonomy of conservative and liberal states is being challenged. Conflicts over undocumented immigrants and the militarization of police have generated tensions between Democratic states and cities.
The Women, Peace and Security Agenda faces global challenges such as complex conflicts and erosion of rights. It proposes to focus on 21st-century security, concrete actions, inclusive mediation, avoiding political instrumentalization, empowering women’s networks, and recognizing their political leadership in peace, closing gender inequality gaps and promoting equality in a changing environment of power and conflict.
The Israeli land offensive in Gaza City, described as genocide by the UN, seeks to control 40% of the territory. Israel rejects the accusations and justifies the war to stay in power. The humanitarian crisis in Gaza worsens with thousands of civilians seeking refuge.
China faces concerns over potential disruptions to the U.S. drug supply chain, driving decoupling measures and support for domestic production. It is vital to prioritize the most relevant chains and develop a comprehensive strategy that includes reviewing critical medicines and their vulnerability, as well as funding availability and political commitment.
Policymakers must understand the relevance of China in U.S. drug supply chains, with a focus on diversifying supplies, reducing dependence on Chinese chemicals, and addressing drug shortages, especially in generics. China has a significant stake in drug inputs, but not as much in active pharmaceutical ingredients.
